Keyphrases
Ceramide
100%
Lipid Analysis
100%
Alcoholic Liver Disease
100%
Phosphatidylcholine
100%
Rifaximin
100%
Placebo
30%
Fibrosis
20%
Lipid Metabolism
20%
Liver Fibrosis
20%
Sphingomyelin
20%
Lipidomics
20%
Treatment Response
10%
Placebo-controlled
10%
Result-oriented
10%
Beneficial Effects
10%
Per-protocol
10%
Mechanism of Action
10%
Therapeutic Target
10%
Phospholipids
10%
Pharmacologic
10%
Lipid Profile
10%
Liver Biopsy
10%
Hepatic Decompensation
10%
Fibrosis Stage
10%
Biopsy-proven
10%
Liver Fibrosis Stage
10%
Lysophosphatidylcholine
10%
Hepatotoxic
10%
Untargeted
10%
Lipid Species
10%
Lipidome
10%
Plasma Lipidomics
10%
Lipid Classes
10%
Fibrosis Score
10%
UHPLC-QTOF-MS
10%
Alcoholic Liver Injury
10%
Pharmacology, Toxicology and Pharmaceutical Science
Ethanol
100%
Liver Disease
100%
Ceramide
100%
Egg Lecithin
100%
Rifaximin
100%
Lipidome
100%
Placebo
40%
Fibrosis
40%
Liver Fibrosis
30%
Sphingomyelin
20%
Randomized Controlled Trial
10%
Liver Injury
10%
Hepatotoxicity
10%
Phospholipid
10%
Ethylenediaminetetraacetic Acid
10%
Ultra High Performance Liquid Chromatography
10%
Decompensated Liver Cirrhosis
10%
Lysophosphatidylcholine
10%
Medicine and Dentistry
Ceramide
100%
Rifaximin
100%
Alcohol-Related Liver Disease
100%
Egg Lecithin
100%
Lipidome
100%
Placebo
40%
Fibrosis
40%
Liver Fibrosis
30%
Lipidomics
30%
Lipid Metabolism
20%
Sphingomyelin
20%
Biopsy
10%
Randomized Controlled Trial
10%
Treatment Response
10%
Phospholipid
10%
Liver Biopsy
10%
Liver Injury
10%
Edetic Acid
10%
Decompensated Liver Cirrhosis
10%
Liver Toxicity
10%
Ultra Performance Liquid Chromatography
10%
Lysophosphatidylcholine
10%
Biochemistry, Genetics and Molecular Biology
Egg Lecithin
100%
Ceramide
100%
Lipidome
100%
Lipidomics
60%
Lipid
40%
Lipid Metabolism
40%
Sphingomyelin
40%
Animal Model
20%
Randomized Controlled Trial
20%
Phospholipid
20%
Lipid Profile
20%
Lysophosphatidylcholine
20%
Ultra High Performance Liquid Chromatography
20%